Gulf Coast TX
Accutar Biotechnology Announces Fast Track Designation Granted by FDA to AC0176 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
BROOKLYN, N.Y.--(BUSINESS WIRE)--Jun 1, 2022-- |!| Rosenberg
